SummaryBackground: Capecitabine is an oral antineoplastic agent classifi ed as a pyrimidin analogue. It is widely used in diff erent types of cancers. Unfortunately, it does not come without a cost, as the drug may have adverse eff ects -largely diarrhea, but also hand-foot syndrome and loss of fi ngerprints in extreme cases. Case: We report a case of a 47-year-old male, which had been dia gnosed with metastatic rectal cancer and received capecitabine, developing a severe hand foot syndrome which led him to lose his fi ngerprints in spite of complete resolution of the syndrome after stoppage of the drug. Conclusion: This case highlights a rare condition that, even though not precisely a disease per se, may hinder patient's quality of life and must be recognised by the treating physician as an treatment related side eff ect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.